Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/8114
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome
Author: Lord, J.
Flight, I.
Norman, R.
Citation: Cochrane Database of Systematic Reviews, 2003; 2003(2):www 1-www 79
Publisher: Update Software Ltd
Issue Date: 2003
ISSN: 1469-493X
1464-780X
Statement of
Responsibility: 
J.M. Lord, I.H.K. Flight and R.J. Norman
Abstract: Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenaemia and insulin resistance. Hyperinsulinaemia is known to be associated with an increase in cardiovascular risk and the development of diabetes mellitus. If insulin sensitising agents such as metformin are effective in treating features of PCOS, then they could have wider health benefits than just treating the symptoms of the syndrome.
Keywords: Humans
Polycystic Ovary Syndrome
Anovulation
Inositol
Metformin
Thiazoles
Thiazolidinediones
Chromans
Hypoglycemic Agents
Ovulation Induction
Female
Randomized Controlled Trials as Topic
Rosiglitazone
Pioglitazone
Troglitazone
Description: Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
DOI: 10.1002/14651858.CD003053
Appears in Collections:Aurora harvest 4
Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.